Selective serotonin-reuptake inhibitors in pregnancy and lactation

Harvard Review of Psychiatry

Volumn 4, Issue 3, 1996, Pages 117-125

  Baum, Antonia L ^a,c   Misri, Shaila ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

COGNITION; FETUS; FETUS DEVELOPMENT; HUMAN; LACTATION; MEDICAL LITERATURE; PREGNANCY; PRIORITY JOURNAL; REVIEW; TERATOGENICITY;

EID: 0029822645     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.3109/10673229609030534     Document Type: Review

References (42)

1. Schatzberg A, Cole J. Manual of clinical psychopharmacology. 2nd ed. Washington, DC: American Psychiatric Press, 1991.
2. Mauro J. And Prozac for all. Psychol Today 1994;27:44-81.
3. Cohen L, Heller V, Rosenbaum J. Treatment guidelines for psychotropic drug use in pregnancy. Psychosomatics 1989;30: 25-33.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994.
5. Levin GM, DeVane CL. Prescribing attitudes of different physician groups regarding fluoxetine. Ann Pharmacother 1993;27:1443-7.
6. Heinonen O, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, Massachusetts: Publishing Sciences Group, 1977.
7. Marchetti F, Romero M, Bonati M, Tognoni G. Use of psychotropic drugs during pregnancy: a report of the international co-operative drug use in pregnancy (DUP) study. Eur J Clin Pharmacol 1993;45:495-501.
8. Auerbach JG, Hans SL, Marcus J, Maeir S. Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol 1992;14:399-406.
9. Elia J, Katz IR, Simpson GM. Teratogenicity of psychotherapeutic medications. Psychopharmacol Bull 1987;23:531-86.
10. Misri S, Sivertz K. Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med 1991;21:157-71.
11. Karasu TB, Docherty J, Gelenberg A, Kupfer DJ, Merriam AE, Shadoan R, et al. Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993;150:l-26.
12. Vorhees CV, Brunner RL, Butcher RE. Psychotropic drugs as behavioral teratogens. Science 1979;205:1220-5.
13. Elia J, Simpson GM. Antidepressant medications during pregnancy and lactation: fetal teratogenic and toxic effects. In: Amsterdam JD, ed. Pharmacotherapy of depression: applications for the outpatient practitioner. New York: Marcel Dekker, 1990:337-79.
14. Pohland RC, Byrd TK, Hamilton M, Koons JR. Placental transfer and fetal distribution of fluoxetine in the rat. Toxicol Appl Pharmacol 1989;98:198-205.
15. 3H-imipramine binding sites in rat cerebral cortex after prenatal exposure to antidepressants. Life Sci 1990;46:1619-26.
16. 2A/2C receptor density and function in male rat progeny following prenatal fluoxetine. J Pharmacol Exp Ther 1994;269:639-45.
17. Goldstein DJ, Williams ML, Pearson DK. Fluoxetine-exposed pregnancies [Abstract]. Clin Research 1991;39:768A.
18. Eli Lilly and Company. Prozac as your first line of action. Scarborough, Ontario: Eli Lilly Canada, 1994.
19. Shuey DL, Sadler TW, Lauder JM. Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors. Teratology 1992; 46:367-78.
20. Stanford MS, Patton JH. In utero exposure to fluoxetine HCl increases hematoma frequency at birth. Pharmacol Biochem Behav 1993;45:959-62.
21. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993;269: 2246-8.
22. Goldstein DJ, Marvel DE. Psychotropic medications during pregnancy: risk to the fetus [Letter]. JAMA 1993;270: 2177.
23. Chambers CD, Johnson KA, Jones KL. Pregnancy outcome in women exposed to fluoxetine. Teratology 1993;47:345-81.
24. Spencer MJ. Fluoxetine hydrochloride (Prozac) toxicity in a neonate. Pediatrics 1993;92:721-2.
25. Goldstein DJ. Effects of third trimester fluoxetine exposure on the newborn. J Clin Psychopharmacol 1995;15:417-20.
26. Buist A, Norman TR, Dennerstein L. Breastfeeding and the use of psychotropic medication: a review. J Affect Disord 1990;19:197-206.
27. Isenberg KE. Excretion of fluoxetine in human breast milk [Letter]. J Clin Psychiatry 1990;51:169.
28. Wright S, Dawling S, Ashford JJ. Excretion of fluvoxamine in breast milk [Letter]. Br J Clin Pharmacol 1991;31:209.
29. Spigset O, Carleborg L, Norström Å, Sandlund M. Paroxetine level in breast milk [Letter]. J Clin Psychiatry 1996;57:39.
30. Lester BM, Cucca J, Andreozzi L, Flanagan P, Oh W. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 1993;32:1253-5.
31. Burch KJ, Wells BG. Fluoxetine/norfluoxetine concentrations in human milk. Pediatrics 1992;89:676-7.
32. Altshuler LL, Burt VK, McMullen M, Hendrick V. Breastfeeding and sertraline: a 24-hour analysis. J Clin Psychiatry 1995;56:243-5.
33. Moos F, Richard P. Serotonergic control of oxytocin release during suckling in the rat: opposite effects in conscious and anesthetized rats. Neuroendocrinology 1983;36:300-6.
34. Novy M. The puerperium. In: DeCherney A, Pernoll M, eds. Current obstetric and gynecologic diagnosis and treatment. 5th ed. Norwalk, Connecticut: Appleton & Lange, 1994.
35. Stoukides C. Can a woman breastfeed while taking Prozac? [Letter]. J Hum Lact 1991;7:144.
36. Miller L. Clinical strategies for the use of psychotropic drugs during pregnancy. Psychiatr Med 1991;9:275-98.
37. Yaryura-Tobias JA, Kirschen H, Ninan P, Mosberg HJ. Fluoxetine and bleeding in obsessive-compulsive disorder [Letter]. Am J Psychiatry 1991;148:949.
38. Miller WH, Bloom JD, Resnick MP. Chronic mental illness and perinatal outcome. Gen Hosp Psychiatry 1992;14:171-6.
39. Cohen L. Psychotropic drug use in pregnancy. Hosp Community Psychiatry 1989;40:566-7.
40. Wisner KL, Perel JM, Wheeler SB. Tricyclic dose requirements across pregnancy. Am J Psychiatry 1993;150:1541-2.
41. Wisner KL, Wheeler SB. Prevention of recurrent postpartum major depression. Hosp Community Psychiatry 1994;45: 1191-6.
42. Cohen LS, Sichel DA, Robertson LM, Heckscher E, Rosenbaum JF. Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry 1995;152:1641-5.